Navigation Links
Sensus Healthcare Announces New Professional Skin Care Line - Sensus Skin Solutions™
Date:1/24/2011

BOCA RATON, Fla., Jan. 24, 2011 /PRNewswire/ -- Sensus Healthcare is pleased to announce its Sensus Skin Solutions™ line of professional skin care products to be exclusively offered by our physician partners.

(Logo: http://photos.prnewswire.com/prnh/20110124/FL34943LOGO)

Cases of skin cancer are on the rise and are dramatically escalating as the population ages. Sensus is taking new aim at skin cancer(SM) in innovative ways. On one front, we are incorporating state-of-the-art mobile X-ray technology for cost-effective, non-invasive treatment of non-melanoma skin cancers with a 98% cure rate. Our signature product, the SRT-100™, utilizes low dose radiotherapy that goes no deeper than the thickness of the skin. On another front, we are working to prevent skin cancer by educating patients about the benefits of good skin care and offering the Sensus Skin Solutions™ professional line that is formulated to help reverse past damage, fight skin problems, and to protect skin from future damage. Our goal is to help patients in protecting their skin from the damage caused by UVA and UVB rays with our advanced titanium-based sunscreen products, together with a daily skin care line in order to maintain healthy and beautiful skin.

Proper skin care and protection are essential components in keeping skin healthy and beautiful for a longer time. Sensus knows it's never too early or too late to begin developing good skin care habits. With the Sensus Skin Solutions™ professional skin care line developed by cosmetic dermatologists and scientists, skin will be protected and renewed, and wrinkles, sun spots, and other discolorations can be diminished. Our products are all-natural, cutting-edge, fast-acting specialized formulations that are available through our physician partners. With a clinician's direction, patients can achieve beautiful, healthy skin with improved appearance and texture while protecting skin from the damaging effects of the sun.

Sensus Healthcare specializes in making proven non-melanoma skin cancer solutions more accessible to patients. Our dedicated low-dose superficial radiation therapy (SRT) systems are designed specifically to provide an alternative to surgical procedures for basal cell and squamous cell carcinomas. Our mobile, compact SRT-100™ systems are used widely by oncologists and dermatologists to bring non-melanoma skin cancer treatment to more patients in more settings. We also offer a professional skin care line, Sensus Skin Solutions™, through our physician partners for their patients. For additional information, please contact:Vicky PerezPublic Relationsvicky@sensushealthcare.com561-922-5808 Ext 108
'/>"/>

SOURCE Sensus Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sensus Healthcare Announces Strategic Partnership With Flagship Solutions Group
2. Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
3. GPhA Statement on the Introduction of the Bipartisan Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
4. New consensus on work-related asthma
5. Anthera Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
6. Biodel Inc. to Present at 29th Annual JPMorgan Healthcare Conference on January 13th, 2011
7. Orexigen® Therapeutics to Present at JP Morgan Healthcare Conference
8. Cellular Dynamics International to Present at 29th Annual JPMorgan Healthcare Conference
9. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
10. ViroPharma to Participate in the 29th Annual J.P. Morgan Healthcare Conference
11. Advanced BioHealing to Present at 29th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
Breaking Biology Technology:
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):